StemRad Company Profile

Background

Overview

StemRad is an Israeli-American company specializing in the development and manufacturing of personal protective equipment (PPE) designed to shield individuals from ionizing radiation. Founded in 2011 by Oren Milstein and Daniel Levitt, the company is headquartered in Tel Aviv, Israel, with additional offices in Tampa, Florida, United States. StemRad's mission is to provide life-saving protection against harmful radiation exposure, ensuring the safety of first responders, military personnel, medical teams, and astronauts without compromising their operational effectiveness.

Mission and Vision

StemRad's mission is to develop innovative radiation protection solutions that safeguard individuals in high-risk environments. The company's vision is to be a global leader in personal radiation protection, offering advanced technologies that enhance safety and performance across various sectors.

Primary Area of Focus

StemRad focuses on creating targeted radiation shielding products that protect critical organs, such as bone marrow, lungs, and reproductive organs, from harmful radiation exposure. This approach allows for effective protection while maintaining mobility and comfort for the wearer.

Industry Significance

As the only company producing PPE specifically designed to protect against high-energy ionizing radiation, StemRad plays a crucial role in enhancing safety protocols for first responders, military personnel, medical professionals, and astronauts. Its innovative solutions address a significant gap in radiation protection, contributing to the advancement of safety standards in various high-risk fields.

Key Strategic Focus

Core Objectives

Innovation in Radiation Protection: Develop cutting-edge technologies that provide effective shielding against ionizing radiation.

Market Expansion: Increase the adoption of StemRad's products across diverse sectors, including defense, healthcare, nuclear energy, and space exploration.

User-Centric Design: Ensure that protective equipment is comfortable, lightweight, and does not impede the wearer's ability to perform essential tasks.

Specific Areas of Specialization

Selective Radiation Shielding: Focusing on protecting specific organs that are most vulnerable to radiation, such as bone marrow, lungs, and reproductive organs.

Ergonomic Design: Creating protective gear that offers mobility and comfort without compromising safety.

Advanced Materials: Utilizing high-density polyethylene and other materials optimized for radiation shielding.

Key Technologies Utilized

High-Density Polyethylene (HDPE): A hydrogenous compound used in StemRad's products to effectively shield against charged particle radiation.

Selective Shielding Technology: An approach that targets protection to specific organs, reducing the overall weight of the protective gear.

Primary Markets Targeted

Defense Sector: Providing radiation protection for military personnel operating in hazardous environments.

Healthcare Sector: Offering protective solutions for medical professionals exposed to ionizing radiation during procedures.

Space Exploration: Developing radiation shielding for astronauts on deep-space missions.

Nuclear Energy Industry: Supplying protective equipment for workers in nuclear facilities.

Financials and Funding

Funding History

StemRad has secured significant funding to support its growth and product development:

Series C Funding Round (December 2017): The company raised $6 million, led by investor Jeff Vinik, owner of the Tampa Bay Lightning. This funding aimed to expand sales and marketing efforts and enhance manufacturing capabilities in the U.S.

Contract with U.S. Department of Defense (December 2023): StemRad was awarded a $4.5 million contract to provide radiation protection equipment for the National Guard, supplying 630 belts and onsite training.

Notable Investors

Jeff Vinik: A prominent investor and owner of the Tampa Bay Lightning, who led the Series C funding round in 2017.

Utilization of Capital

The funds have been directed towards:

Sales and Marketing Expansion: Broadening the reach of StemRad's products across various sectors.

Manufacturing Enhancement: Improving production capabilities to meet increasing demand.

Research and Development: Advancing new protective technologies and products.

Pipeline Development

Key Pipeline Candidates

360 Gamma: A protective belt designed to shield the pelvic bone marrow from gamma radiation, primarily used by first responders and military personnel.

AstroRad Vest: A radiation protection vest developed in collaboration with Lockheed Martin, intended for astronauts on deep-space missions. It has been tested on the International Space Station and was part of NASA's Artemis 1 mission.

StemRad MD: A protective system for medical professionals, featuring an ergonomic design to shield against ionizing radiation during medical procedures.

Stages of Development

360 Gamma: Commercially available and in use by various organizations.

AstroRad Vest: Tested on the International Space Station and included in NASA's Artemis 1 mission.

StemRad MD: Developed and available for medical professionals.

Target Conditions

360 Gamma: Protection against gamma radiation exposure.

AstroRad Vest: Shielding from space radiation, including solar energetic particles.

StemRad MD: Protection against ionizing radiation in medical settings.

Anticipated Milestones

AstroRad Vest: Continued testing and potential adoption in future deep-space missions.

StemRad MD: Wider adoption in medical institutions for radiation protection.

Technological Platform and Innovation

Proprietary Technologies

Selective Shielding Technology: An innovative approach that focuses on protecting specific organs, such as bone marrow, lungs, and reproductive organs, from radiation exposure.

High-Density Polyethylene (HDPE) Shielding: Utilizing HDPE to effectively shield against charged particle radiation, optimizing protection while maintaining comfort and mobility.

Significant Scientific Methods

Radiation Shielding Optimization: Employing scientific methodologies to design protective gear that balances effective shielding with user comfort and mobility.

Leadership Team

Key Executives

Dr. Oren Milstein: Co-founder and CEO of StemRad. With a Ph.D. from The Weizmann Institute of Science, Dr. Milstein has over 12 years of life sciences research experience, focusing on radiation-induced health effects.

Daniel Levitt: Co-founder and Board Member of StemRad. A serial entrepreneur with over 23 years of senior management experience, Levitt has co-founded six high-technology and life-sciences companies.

Shahar Omri: Chief Financial Officer of StemRad. Omri joined the company in October 2018, bringing extensive experience in key finance positions within the high-tech industry.

Competitor Profile

Market Insights and Dynamics

The market for radiation protection equipment is growing, driven by increasing awareness of radiation hazards in various sectors, including defense, healthcare, nuclear energy, and space exploration. StemRad's unique focus on selective shielding positions it as a leader in this niche market.

Competitor Analysis

StemRad operates in a specialized segment with few direct competitors. Companies like Dinco, Maximed, and Lioncare Solutions offer related products but do not provide the same level of targeted radiation protection as StemRad.

Strategic Collaborations and Partnerships

Lockheed Martin: Collaborated to develop the AstroRad vest for astronaut radiation protection.

NASA: Partnered for testing the AstroRad vest on the International Space Station and inclusion in the Artemis 1 mission.

U.S. Department of Defense: Awarded a $4.5 million contract to supply radiation protection equipment for the National Guard.

Operational Insights

StemRad's focus on selective shielding technology provides a competitive advantage by offering effective radiation protection without the weight and bulkiness associated with traditional full-body shielding. This innovation enhances user mobility and comfort, making it more practical for various applications.

Strategic Opportunities and Future Directions

StemRad is well-positioned to expand its product offerings and market reach. Opportunities include:

Medical Sector Expansion: Wider adoption of StemRad MD in medical institutions for radiation protection.

stemrad